Dow Down1.10% Nasdaq Down1.82%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.50 Down 0.07(4.46%) Feb 8, 4:00PM EST
|After Hours : 1.50 Up 0.00 (0.02%) Feb 8, 4:59PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Total Revenue 36,970   81,394   27,587  
Cost of Revenue7,759  6,180  3,671  
Gross Profit 29,211   75,214   23,916  
Operating Expenses
Research Development100,347  66,468  54,112  
Selling General and Administrative34,137  31,681  26,226  
Non Recurring -   -   -  
Others -   -  691  
Total Operating Expenses -   -   -  
Operating Income or Loss (105,273) (22,935) (57,113)
Income from Continuing Operations
Total Other Income/Expenses Net51,680  10,591  (19,244)
Earnings Before Interest And Taxes(53,593)(12,344)(70,019)
Interest Expense6,915  7,091  9,120  
Income Before Tax(60,508)(19,435)(79,139)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(60,508)(19,435)(85,477)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (60,508) (19,435) (85,477)
Preferred Stock And Other Adjustments -   -  (2,824)
Net Income Applicable To Common Shares (60,508) (19,435) (88,301)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.